Oxford PharmaGenesis recently attended the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held in Washington, DC (21–25 May 2016). There was a wide variety of stakeholders in market access and health economics and outcomes research (HEOR) from the pharmaceutical industry, government agencies and academia at the meeting, as…

This month Dr Richard White, our Commercial Director, and Dr Paul Farrow, Communications Director, gave expert talks at the first ever MedComms Brunch Club in Oxford. The links to these talks are below; for further information please click here. Many thanks, as always, to Peter Llewellyn (NetworkPharma) for inviting us to take part in this…

A leading European magazine, Pharmaceutical Marketing Europe, has turned to Oxford PharmaGenesis to update European pharmaceutical executives on how to plan and run advisory board meetings in the digital age.

Medical writers from across Europe gathered in Munich at the 42nd European Medical Writers Association Conference (EMWA, 10–14 May 2016) to network, share best practice and look to the future.

Oxford PharmaGenesis joined this year’s International Society for Medical Publication Professionals Annual Meeting (ISMPP, 11–13 April, 2016; National Harbor, MD, USA), which attracted over 500 publication professionals from the pharmaceutical industries, medical communication agencies, and publishers from around the globe. The attendees were Gordon Muir-Jones, Brian Falcone, Shilpa Aggarwal, Philip Joseph, and Scott Forbes from…

The International Committee of Medical Journal Editors (ICMJE) is consulting on a proposal that authors reporting clinical trials in member journals will be required to share the underlying de-identified individual-patient data with others (Taichman et al., 2016). We believe that this proposal pays insufficient attention to the unique needs of the patients who take part…